#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary hypophosphataemic rickets Haemophagocytic lymphohistiocytosis Synovitis Follicle centre lymphoma follicular grade I II – III refractory Retinitis pigmentosa Cardiomyopathy Prader-Willi syndrome Pericarditis Li-Fraumeni syndrome Mucopolysaccharidosis I SAPHO syndrome Arterial tortuosity syndrome Mastocytosis Short stature homeobox gene mutation Alexander disease More trials…

    Learn about Rare Diseases

    Propionic acidaemia – Basic Information Ocular melanoma – Life with Disease Advanced systemic mastocytosis – Basic Information Glycogen storage disease type I – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Glycogen storage disease type II Ewing’s sarcoma – Trials in Disease Paraneoplastic neurological syndrome – Treatment Medulloblastoma – Treatment Glycogen storage disease type V More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ro7247669 Midazolam Axatilimab Sodium Phosphate Dodecahydrate Omalizumab Specific Nucleic Acid Sna-Xfsb Dronedarone Suxamethonium Chloride Somatostatin Mebeverine Hydrochloride SKB410 Ciclesonide Gskvx000000008866 Mitomycin Bi 3032950 S-241656 Melphalan Follitropin Beta Gen1046 GRISNILIMAB SETARITOX More therapies…

    Learn about Your Condition

    Renal cancer recurrent Primary amyloidosis Neoplasm malignant Viral myocarditis Primary hyperoxaluria Peyronie's disease Giardiasis Premature baby Arthroscopy Procedural pain Herpes simplex Glioblastoma Carcinoid tumour pulmonary Chronic fatigue syndrome Intracranial aneurysm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study on Insulin Eye Drops for Treating Persistent Corneal Epithelial Defect in Patients with Neurotrophic or Chronic Ocular Surface Diseases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Persistent corneal epithelial defect
    Investigated Drugs:
    • Insulin Human
    Spain

  • Study on the Effects of Semaglutide for Patients with Glaucoma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Semaglutide
    Denmark

  • Study on Long-term Safety of JNJ-81201887 for Patients with Geographic Atrophy Due to Age-related Macular Degeneration

    Recruiting

    2 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Adeno-Associated Virus Serotype 2 Encoding Soluble Cd59
    • Prednisone
    • Triamcinolone Acetonide
    Belgium Czechia Denmark Germany Hungary Italy +5

  • Study on the Effectiveness and Safety of Oxymetazoline Hydrochloride Eye Drops for Adults with Acquired Blepharoptosis

    Recruiting

    3 1
    Investigated Drugs:
    • Oxymetazoline Hydrochloride
    Bulgaria Czechia France Germany Hungary Italy +4

  • Study on Tinlarebant for Treating Geographic Atrophy in Patients

    Recruiting

    3 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Tinlarebant
    Czechia France

  • Study Comparing Lidocaine Gel and Tetracaine/Oxybuprocaine Eye Drops for Glaucoma Patients Undergoing Outpatient Needling Procedures

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Oxybuprocaine Hydrochloride
    • Tetracaine Hydrochloride
    Spain
Previous Page
1 … 7 8 9 10 11 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!